What is Verantos?
Verantos operates at the intersection of data science, artificial intelligence, and healthcare, providing a robust RWE platform. This platform is engineered to ingest diverse real-world data, including electronic health records, and transform it into actionable evidence. The accuracy and reliability of the generated RWE are critical, enabling its use in supporting complex clinical assertions, thereby facilitating crucial decisions for regulatory bodies and payers. The company's focus on high-accuracy RWE generation addresses a key industry need for trustworthy data in healthcare.
How much funding has Verantos raised?
Verantos has raised a total of $79K across 1 funding round:
Debt
$79K
Debt (2021): $79K with participation from PPP
What's next for Verantos?
With the recent influx of expansion capital, Verantos is poised to further enhance its RWE platform capabilities and broaden its market reach. The company's strategic positioning within the Series B/C funding lifecycle suggests a focus on scaling operations, potentially expanding its data integration technologies, and deepening its client base among pharmaceutical companies, contract research organizations, and healthcare providers. Continued investment in AI and data science will likely be paramount as Verantos aims to solidify its market leadership and influence healthcare decision-making through advanced real-world evidence.
See full Verantos company page
